Using Biometric Sensor Data to Monitor Cancer Patients During Radiotherapy: Protocol for the OncoWatch Feasibility Study

Cecilie Holländer-Mieritz, Ivan R Vogelius, Claus A Kristensen, Allan Green, Judith L Rindum, Helle Pappot, Cecilie Holländer-Mieritz, Ivan R Vogelius, Claus A Kristensen, Allan Green, Judith L Rindum, Helle Pappot

Abstract

Background: Patients with head and neck cancer (HNC) experience severe side effects during radiotherapy (RT). Ongoing technological advances in wearable biometric sensors allow for the collection of objective data (eg, physical activity and heart rate), which might, in the future, help detect and counter side effects before they become severe. A smartwatch such as the Apple Watch allows for objective data monitoring outside the hospital with minimal effort from the patient. To determine whether such tools can be implemented in the oncological setting, feasibility studies are needed.

Objective: This protocol describes the design of the OncoWatch 1.0 feasibility study that assesses the adherence of patients with HNC to an Apple Watch during RT.

Methods: A prospective, single-cohort trial will be conducted at the Department of Oncology, Rigshospitalet (Copenhagen, Denmark). Patients aged ≥18 years intended for primary or postoperative curatively intended RT for HNC will be recruited. Consenting patients will be asked to wear an Apple Watch on the wrist during and until 2 weeks after RT. The study will include 10 patients. Data on adherence, data acquisition, and biometric data will be collected. Demographic data, objective toxicity scores, and hospitalizations will be documented.

Results: The primary outcome is to determine if it is feasible for the patients to wear a smartwatch continuously (minimum 12 hours/day) during RT. Furthermore, we will explore how the heart rate and physical activity change over the treatment course.

Conclusions: The study will assess the feasibility of using the Apple Watch for home monitoring of patients with HNC. Our findings may provide novel insights into the patient's activity levels and variations in heart rate during the treatment course. The knowledge obtained from this study will be essential for further investigating how biometric data can be used as part of symptom monitoring for patients with HNC.

Trial registration: ClinicalTrials.gov NCT04613232; https://ichgcp.net/clinical-trials-registry/NCT04613232.

International registered report identifier (irrid): PRR1-10.2196/26096.

Keywords: biometric sensor technology; cancer; head and neck cancer; home monitoring; patient-generated health data; radiotherapy; sensor; smartwatch.

Conflict of interest statement

Conflicts of Interest: IRV receives teaching and research contracts from Varian, ViewRay, and Brainlab. The other authors have no conflicts to declare.

©Cecilie Holländer-Mieritz, Ivan R Vogelius, Claus A Kristensen, Allan Green, Judith L Rindum, Helle Pappot. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 13.05.2021.

Figures

Figure 1
Figure 1
Overview of the OncoWatch feasibility study assessment times, tasks, and measures. RT: radiotherapy.
Figure 2
Figure 2
Framework for the OncoWatch 1.0 feasibility study.

References

    1. Jim HSL, Hoogland AI, Brownstein NC, Barata A, Dicker AP, Knoop H, Gonzalez BD, Perkins R, Rollison D, Gilbert SM, Nanda R, Berglund A, Mitchell R, Johnstone PAS. Innovations in research and clinical care using patient-generated health data. CA Cancer J Clin. 2020 May;70(3):182–199. doi: 10.3322/caac.21608. doi: 10.3322/caac.21608.
    1. Piwek L, Ellis DA, Andrews S, Joinson A. The Rise of Consumer Health Wearables: Promises and Barriers. PLoS Med. 2016 Feb;13(2):e1001953. doi: 10.1371/journal.pmed.1001953.
    1. Beg MS, Gupta A, Stewart T, Rethorst CD. Promise of Wearable Physical Activity Monitors in Oncology Practice. J Oncol Pract. 2017 Feb;13(2):82–89. doi: 10.1200/JOP.2016.016857.
    1. Goldsack JC, Coravos A, Bakker JP, Bent B, Dowling AV, Fitzer-Attas C, Godfrey A, Godino JG, Gujar N, Izmailova E, Manta C, Peterson B, Vandendriessche B, Wood WA, Wang KW, Dunn J. Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs) NPJ Digit Med. 2020;3:55. doi: 10.1038/s41746-020-0260-4. doi: 10.1038/s41746-020-0260-4.
    1. Brickwood K, Watson G, O'Brien J, Williams AD. Consumer-Based Wearable Activity Trackers Increase Physical Activity Participation: Systematic Review and Meta-Analysis. JMIR Mhealth Uhealth. 2019 Apr 12;7(4):e11819. doi: 10.2196/11819.
    1. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E, PARSPORT trial management group Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol. 2011 Feb;12(2):127–136. doi: 10.1016/S1470-2045(10)70290-4.
    1. Bentzen SM, Rosenthal DI, Weymuller EA, Trotti A. Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S79–S82. doi: 10.1016/j.ijrobp.2007.04.080.
    1. Machtay M, Moughan J, Trotti A, Garden AS, Weber RS, Cooper JS, Forastiere A, Ang KK. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol. 2008 Jul 20;26(21):3582–3589. doi: 10.1200/JCO.2007.14.8841.
    1. Peterson S, Shinn E, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Baru C, Krueger IH, Farcas E, Rios P, Garden AS, Beadle BM, Lin K, Yan Y, Martch SL, Patrick K. Identifying early dehydration risk with home-based sensors during radiation treatment: a feasibility study on patients with head and neck cancer. J Natl Cancer Inst Monogr. 2013 Dec;2013(47):162–168. doi: 10.1093/jncimonographs/lgt016.
    1. Peterson SK, Garden AS, Shinn EH, Shete S, Martch SL, Camero M, Baum G, Farcas E, Lin K, Raab F, Nandigam V, Yan Y, Ferrarotto R, Godino J, Patrick K, Beadle BM. Using mobile and sensor technology to identify early dehydration risk in head and neck cancer patients undergoing radiation treatment: Impact on symptoms. J Clin Oncol. 2018 May 20;36(15_suppl):6063–6063. doi: 10.1200/JCO.2018.36.15_suppl.6063.
    1. Chung AE, Jensen RE, Basch EM. Leveraging Emerging Technologies and the "Internet of Things" to Improve the Quality of Cancer Care. J Oncol Pract. 2016 Oct;12(10):863–866. doi: 10.1200/JOP.2016.015784.
    1. Low C, Dey A, Ferreira D, Kamarck T, Sun W, Bae S, Doryab A. Estimation of Symptom Severity During Chemotherapy From Passively Sensed Data: Exploratory Study. J Med Internet Res. 2017 Dec 19;19(12):e420. doi: 10.2196/jmir.9046.
    1. King CE, Sarrafzadeh M. A Survey of Smartwatches in Remote Health Monitoring. J Healthc Inform Res. 2018 Jun;2(1-2):1–24. doi: 10.1007/s41666-017-0012-7.
    1. Lu T, Fu C, Ma M, Fang C, Turner A. Healthcare Applications of Smart Watches. A Systematic Review. Appl Clin Inform. 2016 Sep 14;7(3):850–869. doi: 10.4338/ACI-2016-03-R-0042.
    1. Reeder B, David A. Health at hand: A systematic review of smart watch uses for health and wellness. J Biomed Inform. 2016 Oct;63:269–276. doi: 10.1016/j.jbi.2016.09.001.
    1. Beauchamp UL, Pappot H, Holländer-Mieritz C. The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review. JMIR Mhealth Uhealth. 2020 Nov 11;8(11):e22006. doi: 10.2196/22006.
    1. Edbrooke L, Granger CL, Clark RA, Denehy L. Physical Activity Levels Are Low in Inoperable Lung Cancer: Exploratory Analyses from a Randomised Controlled Trial. J Clin Med. 2019 Aug 23;8(9):1288. doi: 10.3390/jcm8091288.
    1. Lowe SS, Danielson B, Beaumont C, Watanabe SM, Baracos VE, Courneya KS. Associations between objectively measured physical activity and quality of life in cancer patients with brain metastases. J Pain Symptom Manage. 2014 Sep;48(3):322–332. doi: 10.1016/j.jpainsymman.2013.10.012.
    1. Nyrop KA, Deal AM, Choi SK, Wagoner CW, Lee JT, Wood A, Anders C, Carey LA, Dees EC, Jolly TA, Reeder-Hayes KE, Muss HB. Measuring and understanding adherence in a home-based exercise intervention during chemotherapy for early breast cancer. Breast Cancer Res Treat. 2018 Feb;168(1):43–55. doi: 10.1007/s10549-017-4565-1.
    1. Eliasen A, Abildtoft M, Krogh N, Rechnitzer C, Brok JS, Mathiasen R, Schmiegelow K, Dalhoff KP. Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process. JMIR Mhealth Uhealth. 2020 Jul 20;8(7):e18564. doi: 10.2196/18564.
    1. Overgaard J, Hansen HS, Specht L, Overgaard M, Grau C, Andersen E, Bentzen J, Bastholt L, Hansen O, Johansen J, Andersen L, Evensen JF. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet. 2003 Sep 20;362(9388):933–940. doi: 10.1016/s0140-6736(03)14361-9.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅